Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Recent Articles

Member Content iKang Forms $74 Million Partnership for New China Healthcare Clinics (in: Deals & Financings)
Member Content China Adds 36 Drugs to NDRL Following Major Price Cuts (in: Gov't & Regulatory)
Member Content Shanghai-Israel Fund Co-Leads $9 Million Funding of Rapid Medical (in: Deals & Financings)
Member Content C-Bridge Closes $400 Million China Healthcare Fund (in: Deals & Financings)
Member Content Ascentage Approved to Start China Trial of Apoptosis Drug (in: Trials & Approvals)
Member Content Suzhou's PegBio Raises $20 Million from Tasly Pharma (in: Deals & Financings)
Member Content CStone Approved to Start China Trials of PD-L1 Candidate (in: Trials & Approvals)
Public Content Week in Review: BGI Genomics Completes $81 Million Chi-Next IPO (in: Week in Review)
Member Content BGI Genomics Climbs 44% after $81 Million Shenzhen IPO (in: Deals & Financings)
Member Content ShangPharma Forms Drug Translation Collaboration with UCSF (in: Deals & Financings)